Why the study?
What is the optimal timing of initiation and duration of dual antiplatelet therapy in coronary patients?
Population
Coronary patients, including stable patients undergoing percutaneous coronary intervention with drug-eluting…
Design
Review
Key result
Recent trials suggest DAPT duration should be individualized, with at least 6 months for stable PCI patients and prolonged therapy for ACS patients tolerating it well.
Authors
Loading...
Supports individualized DAPT decisions in coronary patients; leaves open optimal pre-treatment timing by ACS subtype.
What is the optimal timing of initiation and duration of dual antiplatelet therapy in coronary patients?
Individualized management of DAPT duration is recommended, balancing ischemic benefits against bleeding risks based on patient clinical profiles.
Montalescot et al. (2015) conducted a review in Coronary artery disease / Acute coronary syndrome. Dual antiplatelet therapy (DAPT) was evaluated. Recent trials suggest DAPT duration should be individualized, with at least 6 months for stable PCI patients and prolonged therapy for ACS patients tolerating it well.